Updated guidance was published in December to support primary and community care practitioners in recognising serious pathology which requires emergency or urgent referral to secondary care in people with new or worsening MSK symptoms. Serious pathology as a cause of MSK conditions is considered rare, but it needs to be managed either as an emergency or as urgent onward referral as directed by local pathways. Any part of the MSK system can be affected.
Emergency conditions are serious pathologies which must be dealt with on the day as an emergency.…
Read more of this article
The NASS Facebook Live sessions have been running for about three years now, helping people to manage their axial SpA (AS) in unprecedented times and beyond.… 
Right Start
The Faculty of Sport and Exercise Medicine (UK) has updated their Staying Active at Home resources to include a series of short videos introducing some simple exercises that can be carried out at home, and which are particularly suitable for people who are older or have long-term health conditions. They include exercises that can be performed while sitting, standing, walking or lying down, and were produced with the help of Pure Sports Medicine.
People with fibromyalgia are finding themselves wondering whether they are more at risk of getting Coronavirus, as are other chronically ill and healthy people. The lack of clarity over the origin of our condition does not help in these circumstances. The government uses broad categories to inform people and control risk to vulnerable people. But these broad categories are collecting people and inflaming their anxiety, which does not help their chronic condition.
Many people with rheumatoid arthritis (RA) and their families will be concerned about how the Coronavirus (COVID-19) affects them. NRAS has provided a summary of all the important information that you need to know about Coronavirus and rheumatoid arthritis, including:
NICE has produced new, rapid guidelines on the active management of COVID-19 infection, which are likely to include patients with rheumatoid arthritis. NICE is also reviewing guidance on ibuprofen and other non-steroidal anti-inflammatory drugs in relation to impact on Covid-19 illness. Please see this page: 
